Delivery Order SPE2DB22D2206-SPE2DB25FKA23
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $38,665.68 by the Defense Logistics Agency on August 27, 2025, for the supply of Remicade 100 mg vials. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The product will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 28, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $21,183.76 to AmerisourceBergen Drug Corp for the supply of Remicade 100 mg vials. This firm fixed-price contract, awarded on September 4, 2025, represents a non-competitive set-aside delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion...
- The Defense Logistics Agency awarded a $15,359.26 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Remicade 100 mg vials, with an ultimate completion date of September 22, 2025. This non-set-aside contract represents a competitive award to the pharmaceutical distributor and represents a continuation of AmerisourceBergen's role as a critical supplier of pharmaceutical products to the federal healthcare system. The work will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $12,029.28 to AmerisourceBergen Drug Corp for the supply of Remicade 100 mg vials. The contract is a firm fixed price delivery order with an ultimate completion date of September 22, 2025, and was competitively awarded without set-aside provisions. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $17,733.06 from the Defense Logistics Agency (DLA) on August 25, 2025, for the supply of Remicade 100 mg vials. The contract is competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of August 26, 2025. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,851.46 firm fixed-price delivery order is for 4,564,662,058 units of Remicade 100 mg vials, a specialty medication. The contract has an ultimate completion date of May 21, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,669.41 to AmerisourceBergen Drug Corp for the supply of Remicade 100 mg vials, with an ultimate completion date of September 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under the company's existing Indefinite Delivery Contract (IDC) with...
- This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp for the delivery of Remicade 100 mg vials. The $11,943.91 firm fixed-price contract has an ultimate completion date of July 26, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this delivery order. The contract award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $17,318.52 to AmerisourceBergen Drug Corp for the supply of Remicade 100 mg vials, with an ultimate completion date of August 8, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside procurement and reflects the agency's ongoing pharmaceutical supply needs for military healthcare operations. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,973.67 firm fixed-price delivery order is for the supply of REMICADE 100 MG VIALS, a specialty medication. The contract has an ultimate completion date of November 5, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FKA23Delivery Order
AmerisourceBergen Drug Corp was awarded a delivery order valued at $12,967.93 by the Defense Logistics Agency (DLA) on September 22, 2025, for the supply of Remicade 100 mg vials. The contract represents a firm fixed-price delivery order with an ultimate completion date of September 23, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation and is executed as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive global pharmaceutical support vehicle valued through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive federal contracting portfolio demonstrates its capability to supply a broad range of pharmaceutical products and medical supplies across multiple therapeutic domains. This delivery order for Remicade, a specialty immunosuppressant medication, reflects the company's role in fulfilling specialized pharmaceutical requirements for the Defense Health Agency and other government healthcare systems through the DLA's flexible contracting mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.0k | 9/22/25 |